The present invention relates to HSP90 inhibitors containing a zinc binding moiety and their use in the treatment of cell proliferative diseases such as cancer. The said derivatives may further act as HDAC inhibitors.
-
Page/Page column 30; 39
(2009/04/24)
More Articles about upstream products of 1133784-12-9